Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Glaucoma specialists say they’re often referred post-cataract surgery patients experiencing an IOP spike, many of whom could be treated by the referring surgeon. EyeWorld spoke with two glaucoma specialists to get their insights on what to watch for and management of these cases.
“As we turn our sights toward Washington, D.C., for the 2026 ASCRS Annual Meeting, this quarter’s Glaucoma section highlights a significant maturing of the ‘interventional’ philosophy that has come to define our subspecialty,” said Glaucoma Editor Manjool Shah, MD. Read more in his introduction to the section.
With expanding lens options in cataract surgery and an increase in combined glaucoma and cataract procedures, two ophthalmologists went into detail on when the Light Adjustable Lens (LAL, RxSight) can be a good option for glaucoma patients and considerations when choosing it.
➤ Positive topline data from Phase 3 study for thyroid eye disease treatment ➤ Controlled U.S. release of outflow restoration platform for glaucoma ➤ New platform established to help bring supportive evidence to interventional glaucoma ➤ Head-to-head Phase 1b study supports investigational anti-VEGF ➤ Complimentary access to video journal ➤ ASCRS news and events
Two surgeons discussed benefits to expanding access to the suprachoroidal space, which patients might benefit the most, and other important considerations.
➤ 24-month pivotal data support efficacy of laser treatment for glaucoma ➤ Low-dose atropine drop meets primary, secondary endpoints in new data analysis ➤ Phase 2 topline data for modifier gene therapy for geographic atrophy ➤ Phase 2 data from study evaluating neuropathic corneal pain shows quality of life improvement ➤ New shelf-stable corneal endothelial cell therapy program begins ➤ ASCRS news and events
ASCRS Subspecialty Day will take place on Friday, April 10, ahead of the 2026 ASCRS Annual Meeting, and promises exciting content across the fields of cornea, glaucoma, and refractive surgery.
➤ FDA approves new EDOF with limited dysphotopsias ➤ Phase 1/2 12-month data for IOL-based drug delivery system ➤ Topline results from Phase 2a wet AMD study ➤ FDA grants Breakthrough Device Designation to brain implant technology ➤ FDA allows Phase 1/2 trial to begin for investigational cell therapy for familial drusen ➤ ASCRS news and events
➤ Positive results in Phase 3 superiority trial for wet AMD treatment ➤ Dosing begins for first-in-human myopia prevention drop ➤ Pre-NDA meeting with FDA for IOP-lowering drop ➤ Company news ➤ ASCRS news and events
➤ New drop for temporary presbyopia relief approved ➤ First-in-human results for accommodating IOL ➤ Enrollment complete in Phase 2/3 trial for Stargardt therapy ➤ Type C meeting completed with FDA to advance urcosimod for neuropathic corneal pain ➤ Company news ➤ ASCRS news and events